- Home
- ABP vs HSCS Comparison
ABP vs HSCS Comparison
Compare ABP & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABP | HSCS |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 11.0M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | ABP | HSCS |
|---|---|---|
| Price | $1.09 | $3.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $9.20 |
| AVG Volume (30 Days) | ★ 4.0M | 30.5K |
| Earning Date | 04-02-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $8,669.00 |
| Revenue This Year | N/A | $1,072.41 |
| Revenue Next Year | N/A | $2,700.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 50.00 | N/A |
| 52 Week Low | $1.12 | $2.01 |
| 52 Week High | $34.65 | $6.47 |
Technical Indicators
Market Signals| Indicator | ABP | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 21.88 | 49.34 |
| Support Level | $1.44 | $2.72 |
| Resistance Level | $2.89 | $3.25 |
| Average True Range (ATR) | 0.38 | 0.19 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 0.01 | 52.46 |
Price Performance
Historical ComparisonAbout ABP Abpro Holdings Inc
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.